Literature DB >> 10984571

Perinatal exposure to zidovudine--benefits and risks.

L M Mofenson.   

Abstract

Entities:  

Keywords:  Health Care and Public Health; Professional Patient Relationship

Mesh:

Substances:

Year:  2000        PMID: 10984571     DOI: 10.1056/NEJM200009143431110

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Perinatal exposure to antiretroviral agents: risks and benefits.

Authors:  Gwendolyn B Scott
Journal:  AJNR Am J Neuroradiol       Date:  2005-04       Impact factor: 3.825

Review 2.  Mitochondrial toxicity and HIV therapy.

Authors:  A J White
Journal:  Sex Transm Infect       Date:  2001-06       Impact factor: 3.519

Review 3.  The role of non-nucleoside reverse transcriptase inhibitors in children with HIV-1 infection.

Authors:  S Maddocks; D Dwyer
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

4.  A pilot study to evaluate the safety and feasibility of the administration of AZT/3TC fixed dose combination to HIV infected pregnant women and their infants in Rio de Janeiro, Brazil.

Authors:  J S Lambert; S A Nogueira; T Abreu; E S Machado; T P Costa; M Bondarovsky; M Andrade; M Halpern; R Barbosa; M Perez
Journal:  Sex Transm Infect       Date:  2003-12       Impact factor: 3.519

5.  Pathology in children of HIV women.

Authors:  Ana Pilar Nso Roca; C García-Bermejo García-Bermejo; B Larru; Madero R; M A Muñoz Fernández; M I de José
Journal:  Indian J Pediatr       Date:  2009-11       Impact factor: 1.967

Review 6.  Mitochondrial disorders among infants exposed to HIV and antiretroviral therapy.

Authors:  Michele Jonsson Funk; Suzanne E Belinson; Jeanne M Pimenta; Megan Morsheimer; David C Gibbons
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.